Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Giardini

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Haematologica|June 15, 1999
Cytogenetic and molecular characterization of T-cell acute lymphoblastic leukemia as a second tumor after anaplastic large-cell lymphoma in a boyD Perotti, G Sozzi, A Ferrari, et al.
Blood|July 27, 2000
Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusionM Magni, M Di Nicola, L Devizzi, et al.
British Journal of Cancer|April 13, 2013
Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancerG Allevi, C Strina, D Andreis, et al.
The American Journal of Pathology|September 15, 1998
ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrumB Falini, B Bigerna, M Fizzotti, et al.
Blood|April 9, 1999
ALK+ lymphoma: clinico-pathological findings and outcomeB Falini, S Pileri, P L Zinzani, et al.
British Journal of Cancer|December 3, 2014
Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancerL Bazzola, C Foroni, D Andreis, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Haematologica|June 15, 1999
Cytogenetic and molecular characterization of T-cell acute lymphoblastic leukemia as a second tumor after anaplastic large-cell lymphoma in a boyD Perotti, G Sozzi, A Ferrari, et al.
Blood|July 27, 2000
Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusionM Magni, M Di Nicola, L Devizzi, et al.
British Journal of Cancer|April 13, 2013
Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancerG Allevi, C Strina, D Andreis, et al.
The American Journal of Pathology|September 15, 1998
ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrumB Falini, B Bigerna, M Fizzotti, et al.
Blood|April 9, 1999
ALK+ lymphoma: clinico-pathological findings and outcomeB Falini, S Pileri, P L Zinzani, et al.
British Journal of Cancer|December 3, 2014
Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancerL Bazzola, C Foroni, D Andreis, et al.
Pageof 8